Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yangxue Jiedu Tang is a Traditional Chinese Medicine (TCM) herbal decoction developed by the Beijing Hospital of Traditional Chinese Medicine for the treatment of psoriasis vulgaris, specifically targeting the blood dryness syndrome. The formula is designed to nourish the blood and detoxify the body. Clinical and preclinical research indicates that the formula promotes microvessel regression in psoriatic lesions, potentially by modulating the Survivin-PI3K-beta-catenin signaling pathway. It is typically administered orally and has been evaluated in clinical trials both as a monotherapy and in combination with external emollients like white vaseline.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on yangxue jiedu tang.